SCHEMBL6304529

SCHEMBL6304529

Cc1coc2c(Br)c(F)c(F)c(F)c12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALDH2 P05091 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16004961 0.73 ALDH2 (0.33) ALDH2
SCHEMBL19584837 0.67 F2RL1 (0.43) ALDH2
SCHEMBL5987345 0.65 ALDH2 (0.37) ALDH2
SCHEMBL20844203 0.64 — —
SCHEMBL6305348 0.63 KCNA3 (0.39) —
SCHEMBL5040005 0.61 ALDH2 (0.35) ALDH2
SCHEMBL18876378 0.60 ALDH2 (0.31) ALDH2
SCHEMBL20793966 0.60 ALDH2 (0.41) ALDH2
SCHEMBL5986722 0.59 KCNA3 (0.36) —
SCHEMBL13725473 0.59 KCNA3 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6967201-B1 for increasing activation of the 5-HT2C receptor in mammals; treatment of depression, obesity, bulimia, premenstrual syndrome, alcoholism, tobacco abuse, panic disorder ELI LILLY AND COMPANY (US) 2005-11-22 — — US disclosed
EP-1204654-B1 BENZOFURYLPIPERAZINES: 5-HT2C SEROTONIN RECEPTOR AGONISTS LILLY CO ELI (US) 2003-07-23 — — EP disclosed
Send feedback